Skip to main content

Part of the book series: SpringerBriefs in Immunology ((BRIEFSIMMUN))

  • 470 Accesses

Abstract

Interleukin-27 plays an important role in the regulation of immune response. IL-27 activates multiple signaling cascades, including the JAK-STAT, Akt/mTOR, ERK, and p38 MAPK pathways. Multiple studies have revealed that IL-27 regulates Th1, Th2, Th17, Treg, Tr1, Tfh T cell population, as well as B cells, DCs, and macrophages. Due to its broad inhibitory effects, IL-27 is pivotal in maintenance of fetomaternal tolerance and prevention of autoimmunity. However, the same broad inhibitory capabilities seem to compromise immune response to bacterial pathogens. Here, we have discussed the role of IL-27 in bacterial, viral, and parasitic infections, chronic inflammation in asthma, COPD, psoriasis and inflammatory bowel disease and autoimmune disorders, such as systemic lupus erythematosus, rheumatoid arthritis, Sjogren’s syndrome, autoimmune uveitis, multiple sclerosis, and autoimmune thrombocytopenia. IL-27 represents also a novel, promising target/agent for the treatment of cancer; however, protumor activities have also been reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Airoldi I, Tupone MG, Esposito S, Russo MV, Barbarito G, Cipollone G, Di Carlo E (2015) Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer. Oncotarget 6(6):3694–3708. doi:10.18632/oncotarget.2797

    Article  PubMed  PubMed Central  Google Scholar 

  • Amadi-Obi A, Yu CR, Dambuza I, Kim SH, Marrero B, Egwuagu CE (2012) Interleukin 27 induces the expression of complement factor H (CFH) in the retina. PLoS ONE 7(9):e45801. doi:10.1371/journal.pone.0045801

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anderson CF, Stumhofer JS, Hunter CA, Sacks D (2009) IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol 183(7):4619–4627. doi:10.4049/jimmunol.0804024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Angata T, Ishii T, Gao C, Ohtsubo K, Kitazume S, Gemma A, Kida K, Taniguchi N (2014) Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary disease. Phys Rep 2(7). doi:10.14814/phy2.12069

    Google Scholar 

  • Babaloo Z, Yeganeh RK, Farhoodi M, Baradaran B, Bonyadi M, Aghebati L (2013) Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis. Iranian journal of immunology: IJI 10 (1):47-54. doi:IJIv10i1A6

    Google Scholar 

  • Baker BJ, Park KW, Qin H, Ma X, Benveniste EN (2010) IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58(9):1082–1093. doi:10.1002/glia.20989

    Article  PubMed  PubMed Central  Google Scholar 

  • Barreto-de-Souza V, Ferreira PL, Vivarini Ade C, Calegari-Silva T, Soares DC, Regis EG, Pereira RM, Silva AM, Saraiva EM, Lopes UG, Bou-Habib DC (2015) IL-27 enhances Leishmania amazonensis infection via ds-RNA dependent kinase (PKR) and IL-10 signaling. Immunobiology 220(4):437–444. doi:10.1016/j.imbio.2014.11.006

    Article  CAS  PubMed  Google Scholar 

  • Batista MD, Tincati C, Milush JM, Ho EL, Ndhlovu LC, York VA, Kallas EG, Kalil J, Keating SM, Norris PJ, Chang D, Unemori P, Leslie KS, Maurer T, Liao W, Nixon DF (2013) CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis. PLoS ONE 8(2):e52144. doi:10.1371/journal.pone.0052144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7(9):929–936. doi:10.1038/ni1375

    Article  CAS  PubMed  Google Scholar 

  • Bhoria P, Sharma S, Varma N, Malhotra P, Varma S, Luthra-Guptasarma M (2015) Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP). Platelets 26(2):119–126. doi:10.3109/09537104.2014.888546

    Article  CAS  PubMed  Google Scholar 

  • Bornsen L, Romme Christensen J, Ratzer R, Hedegaard C, Sondergaard HB, Krakauer M, Hesse D, Nielsen CH, Sorensen PS, Sellebjerg F (2015) Endogenous interferon-beta-inducible gene expression and interferon-beta-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. PLoS ONE 10(3):e0118830. doi:10.1371/journal.pone.0118830

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bosmann M, Strobl B, Kichler N, Rigler D, Grailer JJ, Pache F, Murray PJ, Muller M, Ward PA (2014) Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27. J Leukoc Biol 96(1):123–131. doi:10.1189/jlb.3A1013-541R

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Campanati A, Orciani M, Consales V, Lazzarini R, Ganzetti G, Di Benedetto G, Di Primio R, Offidani A (2014) Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis. Arch Dermatol Res 306(10):915–920. doi:10.1007/s00403-014-1493-3

    Article  CAS  PubMed  Google Scholar 

  • Canale S, Cocco C, Frasson C, Seganfreddo E, Di Carlo E, Ognio E, Sorrentino C, Ribatti D, Zorzoli A, Basso G, Dufour C, Airoldi I (2011) Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. Leukemia 25(12):1815–1824. doi:10.1038/leu.2011.158

    Article  CAS  PubMed  Google Scholar 

  • Cao J, Wang D, Xu F, Gong Y, Wang H, Song Z, Li D, Zhang H, Zhang L, Xia Y, Xu H, Lai X, Lin S, Zhang X, Ren G, Dai Y, Yin Y (2014a) Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia. EMBO Mol Med 6(1):120–140. doi:10.1002/emmm.201302890

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cao J, Xu F, Lin S, Song Z, Zhang L, Luo P, Xu H, Li D, Zheng K, Ren G, Yin Y (2014b) IL-27 controls sepsis-induced impairment of lung antibacterial host defence. Thorax 69(10):926–937. doi:10.1136/thoraxjnl-2014-205777

    Article  PubMed  Google Scholar 

  • Cao J, Zhang L, Li D, Xu F, Huang S, Xiang Y, Yin Y, Ren G (2012) IL-27 is elevated in patients with COPD and patients with pulmonary TB and induces human bronchial epithelial cells to produce CXCL10. Chest 141(1):121–130. doi:10.1378/chest.10-3297

    Article  CAS  PubMed  Google Scholar 

  • Cao Y, Zhang R, Zhang W, Zhu C, Yu Y, Song Y, Wang Q, Bai L, Liu Y, Wu K, Wu J (2014c) IL-27, a cytokine, and IFN-lambda1, a type III IFN, are coordinated to regulate virus replication through type I IFN. J Immunol 192(2):691–703. doi:10.4049/jimmunol.1300252

    Article  CAS  PubMed  Google Scholar 

  • Carbotti G, Barisione G, Airoldi I, Mezzanzanica D, Bagnoli M, Ferrero S, Petretto A, Fabbi M, Ferrini S (2015) IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Oncotarget 6(41):43267–43280. doi:10.18632/oncotarget.6530

    PubMed  PubMed Central  Google Scholar 

  • Chen P, Gong Y, Pu Y, Wang Y, Zhou B, Song Y, Wang T, Zhang L (2016) Association between polymorphisms in IL-27 gene and pre-eclampsia. Placenta 37:61–64. doi:10.1016/j.placenta.2015.11.003

    Article  CAS  PubMed  Google Scholar 

  • Chen Q, Swaminathan S, Yang D, Dai L, Sui H, Yang J, Hornung RL, Wang Y, da Huang W, Hu X, Lempicki RA, Imamichi T (2013) Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway. PLoS ONE 8(3):e59194. doi:10.1371/journal.pone.0059194

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiba Y, Mizoguchi I, Mitobe K, Higuchi K, Nagai H, Nishigori C, Mizuguchi J, Yoshimoto T (2013) IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with a TLR3 agonist poly(I:C) partly in a TRAIL-dependent manner. PLoS ONE 8(10):e76159. doi:10.1371/journal.pone.0076159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, Tagawa M (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 115(3):437–442. doi:10.1002/ijc.20848

    Article  CAS  PubMed  Google Scholar 

  • Chong WP, van Panhuys N, Chen J, Silver PB, Jittayasothorn Y, Mattapallil MJ, Germain RN, Caspi RR (2015) NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis. J Exp Med 212(10):1739–1752. doi:10.1084/jem.20141678

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cocco C, Di Carlo E, Zupo S, Canale S, Zorzoli A, Ribatti D, Morandi F, Ognio E, Airoldi I (2012a) Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia 26(6):1365–1374. doi:10.1038/leu.2011.363

    Article  CAS  PubMed  Google Scholar 

  • Cocco C, Giuliani N, Di Carlo E, Ognio E, Storti P, Abeltino M, Sorrentino C, Ponzoni M, Ribatti D, Airoldi I (2010) Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin Cancer Res (an official journal of the American Association for Cancer Research) 16(16):4188–4197. doi:10.1158/1078-0432.CCR-10-0173

    Article  CAS  Google Scholar 

  • Cocco C, Pistoia V, Airoldi I (2012b) Anti-leukemic properties of IL-12, IL-23 and IL-27: differences and similarities in the control of pediatric B acute lymphoblastic leukemia. Crit Rev Oncol/Hematol 83(3):310–318. doi:10.1016/j.critrevonc.2011.11.006

    Article  Google Scholar 

  • Coulomb-L’Hermine A, Larousserie F, Pflanz S, Bardel E, Kastelein RA, Devergne O (2007) Expression of interleukin-27 by human trophoblast cells. Placenta 28(11–12):1133–1140. doi:10.1016/j.placenta.2007.06.004

    Article  PubMed  CAS  Google Scholar 

  • Cox JH, Kljavin NM, Ramamoorthi N, Diehl L, Batten M, Ghilardi N (2011) IL-27 promotes T cell-dependent colitis through multiple mechanisms. J Exp Med 208(1):115–123. doi:10.1084/jem.20100410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM (2011) An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35(5):792–805. doi:10.1016/j.immuni.2011.09.017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dai L, Lidie KB, Chen Q, Adelsberger JW, Zheng X, Huang D, Yang J, Lempicki RA, Rehman T, Dewar RL, Wang Y, Hornung RL, Canizales KA, Lockett SJ, Lane HC, Imamichi T (2013) IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation. J Exp Med 210(3):517–534. doi:10.1084/jem.20120572

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Mercanti S, Rolla S, Cucci A, Bardina V, Cocco E, Vladic A, Soldo-Butkovic S, Habek M, Adamec I, Horakova D, Annovazzi P, Novelli F, Durelli L, Clerico M (2016) Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. Neurol(R) Neuroimmunol Neuroinflammation 3(1):e194. doi:10.1212/NXI.0000000000000194

    Google Scholar 

  • Di Carlo E, Sorrentino C, Zorzoli A, Di Meo S, Tupone MG, Ognio E, Mincione G, Airoldi I (2014) The antitumor potential of Interleukin-27 in prostate cancer. Oncotarget 5(21):10332–10341. doi:10.18632/oncotarget.1425

    Article  PubMed  PubMed Central  Google Scholar 

  • Dibra D, Mitra A, Newman M, Xia X, Cutrera JJ, Gagea M, Kleinerman ES, Lozano G, Li S (2016) Lack of immunomodulatory Interleukin-27 enhances oncogenic properties of mutant p53 in vivo. Clin Cancer Res (an official journal of the American Association for Cancer Research). doi:10.1158/1078-0432.CCR-15-2052

    Google Scholar 

  • Diegelmann J, Olszak T, Goke B, Blumberg RS, Brand S (2012) A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem 287(1):286–298. doi:10.1074/jbc.M111.294355

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Do JS, Visperas A, Sanogo YO, Bechtel JJ, Dvorina N, Kim S, Jang E, Stohlman SA, Shen B, Fairchild RL, Baldwin Iii WM, Vignali DA, Min B (2016) An IL-27/Lag3 axis enhances Foxp3(+) regulatory T cell-suppressive function and therapeutic efficacy. Mucosal Immunol 9(1):137–145. doi:10.1038/mi.2015.45

    Article  CAS  PubMed  Google Scholar 

  • Dong S, Zhang X, He Y, Xu F, Li D, Xu W, Wang H, Yin Y, Cao J (2013) Synergy of IL-27 and TNF-alpha in regulating CXCL10 expression in lung fibroblasts. Am J Respir Cell Mol Biol 48(4):518–530. doi:10.1165/rcmb.2012-0340OC

    Article  CAS  PubMed  Google Scholar 

  • Duan M, Ning Z, Fu Z, Zhang J, Liu G, Wei Q, Zheng X (2015) Decreased IL-27 negatively correlated with Th17 cells in non-small-cell lung cancer patients. Mediat Inflamm 2015:802939. doi:10.1155/2015/802939

    Google Scholar 

  • Duarte AL, Dantas AT, de Ataide Mariz H, dos Santos FA, da Silva JC, da Rocha LF Jr, Galdino SL, Galdino da Rocha Pitta M (2013) Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients. Mol Biol Rep 40(8):4889–4892. doi:10.1007/s11033-013-2588-1

    Google Scholar 

  • El-behi M, Ciric B, Yu S, Zhang GX, Fitzgerald DC, Rostami A (2009) Differential effect of IL-27 on developing versus committed Th17 cells. J Immunol 183(8):4957–4967. doi:10.4049/jimmunol.0900735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feng J, Xia Y, Yuan L, Chen A, Yang N, Xiang Y, Xiang S (2015) [An increased level of interleukin 27 in peripheral blood mononuclear cells and fibroblasts like synoviocytes of patients with rheumatoid arthritis or osteoarthritis]. Xi bao yu fen zi mian yi xue za zhi = Chin J Cell Mol Immunol 31(12):1673–1676

    Google Scholar 

  • Feng XM, Chen XL, Liu N, Chen Z, Zhou YL, Han ZB, Zhang L, Han ZC (2007) Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Hum Immunol 68(12):965–972. doi:10.1016/j.humimm.2007.10.004

    Article  CAS  PubMed  Google Scholar 

  • Ferrante A, Ciccia F, Principato A, Giardina AR, Impastato R, Peralta S, Triolo G (2010) A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behcet’s disease. Clin Exp Rheumatol 28(4 Suppl 60):S27–S30

    PubMed  Google Scholar 

  • Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A (2007) Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372–1379. doi:10.1038/ni1540

    Article  CAS  PubMed  Google Scholar 

  • Frank AC, Zhang X, Katsounas A, Bharucha JP, Kottilil S, Imamichi T (2010) Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. J Interferon Cytokine Res (the official journal of the International Society for Interferon and Cytokine Research) 30(6):427–431. doi:10.1089/jir.2009.0093

    Article  CAS  Google Scholar 

  • Fu H, Tang YY, Ouyang XP, Tang SL, Su H, Li X, Huang LP, He M, Lv YC, He PP, Yao F, Tan YL, Xie W, Zhang M, Wu J, Li Y, Chen K, Liu D, Lan G, Zeng MY, Zheng XL, Tang CK (2014) Interleukin-27 inhibits foam cell formation by promoting macrophage ABCA1 expression through JAK2/STAT3 pathway. Biochem Biophys Res Commun 452(4):881–887. doi:10.1016/j.bbrc.2014.08.120

    Article  CAS  PubMed  Google Scholar 

  • Golden-Mason L, Waasdorp Hurtado CE, Cheng L, Rosen HR (2015) Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3. Clin Immunol 158(1):114–125. doi:10.1016/j.clim.2015.03.008

    Article  CAS  PubMed  Google Scholar 

  • Gonin J, Carlotti A, Dietrich C, Audebourg A, Radenen-Bussiere B, Caignard A, Avril MF, Vacher-Lavenu MC, Larousserie F, Devergne O (2013) Expression of IL-27 by tumor cells in invasive cutaneous and metastatic melanomas [corrected]. PLoS ONE 8(10):e75694. doi:10.1371/journal.pone.0075694

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greenwell-Wild T, Vazquez N, Jin W, Rangel Z, Munson PJ, Wahl SM (2009) Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 114(9):1864–1874. doi:10.1182/blood-2009-03-211540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guzzo C, Ayer A, Basta S, Banfield BW, Gee K (2012) IL-27 enhances LPS-induced proinflammatory cytokine production via upregulation of TLR4 expression and signaling in human monocytes. J Immunol 188(2):864–873. doi:10.4049/jimmunol.1101912

    Article  CAS  PubMed  Google Scholar 

  • Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, Zhang M, Hisaeda H, Mak TW, Yoshimura A, Yoshida H (2003) WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19(5):657–667

    Article  CAS  PubMed  Google Scholar 

  • Hamzeh-Cognasse H, Damien P, Nguyen KA, Arthaud CA, Eyraud MA, Chavarin P, Absi L, Osselaer JC, Pozzetto B, Cognasse F, Garraud O (2014) Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion 54(3):613–625. doi:10.1111/trf.12378

    Article  CAS  PubMed  Google Scholar 

  • Hamzeh-Cognasse H, Damien P, Nguyen KA, Zeni F, Pozzetto B, Cognasse F, Garraud O (2013) Contribution of activated platelets to plasma IL-27 levels. Crit Care 17(1):411. doi:10.1186/cc11925

    Article  PubMed  PubMed Central  Google Scholar 

  • Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA, Janelsins BM, Datta SK, Shen W, McLean MH, Durum SK (2014) Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146(1):210–221 e213. doi:10.1053/j.gastro.2013.09.060

    Google Scholar 

  • Harker JA, Dolgoter A, Zuniga EI (2013) Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4(+) T cell responses and viral control during chronic infection. Immunity 39(3):548–559. doi:10.1016/j.immuni.2013.08.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hawlisch H, Belkaid Y, Baelder R, Hildeman D, Gerard C, Kohl J (2005) C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22(4):415–426. doi:10.1016/j.immuni.2005.02.006

    Article  CAS  PubMed  Google Scholar 

  • He L, Zhao J, Wang MH, Siu KK, Gan YX, Chen L, Zee BC, Yang L, Kung HF, Yang ZR, He ML (2014) Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naive HIV-mono-infected and HIV/HCV-co-infected Chinese. PloS one 9(5):e96792. doi:10.1371/journal.pone.0096792

    Google Scholar 

  • Hirahara K, Ghoreschi K, Yang XP, Takahashi H, Laurence A, Vahedi G, Sciume G, Hall AO, Dupont CD, Francisco LM, Chen Q, Tanaka M, Kanno Y, Sun HW, Sharpe AH, Hunter CA, O’Shea JJ (2012) Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36(6):1017–1030. doi:10.1016/j.immuni.2012.03.024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirase T, Hara H, Miyazaki Y, Ide N, Nishimoto-Hazuku A, Fujimoto H, Saris CJ, Yoshida H, Node K (2013) Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. Am J Physiol Heart Circ Physiol 305(3):H420–H429. doi:10.1152/ajpheart.00198.2013

    Article  CAS  PubMed  Google Scholar 

  • Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y, Mizuguchi J, Yoshimoto T (2004) Potent antitumor activity of interleukin-27. Cancer Res 64(3):1152–1156

    Article  CAS  PubMed  Google Scholar 

  • Ho MY, Leu SJ, Sun GH, Tao MH, Tang SJ, Sun KH (2009) IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities. J Immunol 183(10):6217–6226. doi:10.4049/jimmunol.0901272

    Article  CAS  PubMed  Google Scholar 

  • Hobbs BD, Parker MM, Chen H, Lao T, Hardin M, Qiao D, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Castaldi PJ, Hersh CP, Morrow J, Celli BR, Pinto-Plata VM, Criner GJ, Marchetti N, Bueno R, Agusti A, Make BJ, Crapo JD, Calverley PM, Donner CF, Lomas DA, Wouters EF, Vestbo J, Pare PD, Levy RD, Rennard SI, Zhou X, Laird NM, Lin X, Beaty TH, Silverman EK, Cho MH (2016) Exome array analysis identifies a common variant in IL27 associated with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. doi:10.1164/rccm.201510-2053OC

    PubMed  Google Scholar 

  • Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S (2005) The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174(6):3534–3544

    Article  PubMed  Google Scholar 

  • Hu P, Hu HD, Chen M, Peng ML, Tang L, Tang KF, Matsui M, Belladonna ML, Yoshimoto T, Zhang DZ, Xiang R, Ren H (2009) Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma. Mol Immunol 46(8–9):1654–1662. doi:10.1016/j.molimm.2009.02.025

    Article  CAS  PubMed  Google Scholar 

  • Huang N, Liu L, Wang XZ, Liu D, Yin SY, Yang XD (2008) Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol 27(9):527–531. doi:10.1089/dna.2007.0715

    Article  CAS  PubMed  Google Scholar 

  • Huber M, Steinwald V, Guralnik A, Brustle A, Kleemann P, Rosenplanter C, Decker T, Lohoff M (2008) IL-27 inhibits the development of regulatory T cells via STAT3. Int Immunol 20(2):223–234. doi:10.1093/intimm/dxm139

    Article  CAS  PubMed  Google Scholar 

  • Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, Dubinsky M, Kugathasan S, Bradfield JP, Walters TD, Sleiman P, Kim CE, Muise A, Wang K, Glessner JT, Saeed S, Zhang H, Frackelton EC, Hou C, Flory JH, Otieno G, Chiavacci RM, Grundmeier R, Castro M, Latiano A, Dallapiccola B, Stempak J, Abrams DJ, Taylor K, McGovern D, Silber G, Wrobel I, Quiros A, Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmuda MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwillam R, Tremelling M, Delukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ, Heyman MB, Ferry GD, Kirschner B, Lee J, Essers J, Grand R, Stephens M, Levine A, Piccoli D, Van Limbergen J, Cucchiara S, Monos DS, Guthery SL, Denson L, Wilson DC, Grant SF, Daly M, Hakonarson H (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41(12):1335–1340. doi:10.1038/ng.489

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jin W, Zhao Y, Yan W, Cao L, Zhang W, Wang M, Zhang T, Fu Q, Li Z (2012) Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis. Mediat Inflamm 2012:506283. doi:10.1155/2012/506283

    Google Scholar 

  • Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, Cardus A, Williams AS, Pitzalis C, Jenkins BJ, Jones SA (2015) Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med 212(11):1793–1802. doi:10.1084/jem.20132307

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung JY, Roberts LL, Robinson CM (2015) The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells. Immunology 144(4):649–660. doi:10.1111/imm.12417

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jung JY, Robinson CM (2014) IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages. Cell Commun Signal CCS 12:16. doi:10.1186/1478-811X-12-16

    Article  PubMed  CAS  Google Scholar 

  • Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM (2013) IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res CR 32:97. doi:10.1186/1756-9966-32-97

    Article  PubMed  CAS  Google Scholar 

  • Kanagavelu S, Flores C, Termini JM, Riveron R, Romero L, Chung K, Ruiz J, Hyun J, Yuan X, Dagvadorj J, Fukata M (2015) TIR-domain-containing adapter-inducing interferon-beta (TRIF) regulates Th17-mediated intestinal immunopathology in colitis. Mucosal Immunol 8(2):296–306. doi:10.1038/mi.2014.67

    Google Scholar 

  • Kanda N, Watanabe S (2008) IL-12, IL-23, and IL-27 enhance human beta-defensin-2 production in human keratinocytes. Eur J Immunol 38(5):1287–1296. doi:10.1002/eji.200738051

    Article  CAS  PubMed  Google Scholar 

  • Karakhanova S, Bedke T, Enk AH, Mahnke K (2011) IL-27 renders DC immunosuppressive by induction of B7-H1. J Leukoc Biol 89(6):837–845. doi:10.1189/jlb.1209788

    Article  CAS  PubMed  Google Scholar 

  • Kawanokuchi J, Takeuchi H, Sonobe Y, Mizuno T, Suzumura A (2013) Interleukin-27 promotes inflammatory and neuroprotective responses in microglia. Clin Exp Neuroimmunol 4:36–45. doi:10.1111/cen3.12005

    Article  CAS  Google Scholar 

  • Kido M, Takeuchi S, Sugiyama N, Esaki H, Nakashima H, Yoshida H, Furue M (2011) T cell-specific overexpression of interleukin-27 receptor alpha subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice. Br J Dermatol 164(6):1214–1220. doi:10.1111/j.1365-2133.2011.10244.x

    Article  CAS  PubMed  Google Scholar 

  • Kim G, Shinnakasu R, Saris CJ, Cheroutre H, Kronenberg M (2013) A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes. J Immunol 190(4):1510–1518. doi:10.4049/jimmunol.1201017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kole A, He J, Rivollier A, Silveira DD, Kitamura K, Maloy KJ, Kelsall BL (2013) Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis. J Immunol 191(5):2771–2779. doi:10.4049/jimmunol.1301093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Koltsova EK, Kim G, Lloyd KM, Saris CJ, von Vietinghoff S, Kronenberg M, Ley K (2012) Interleukin-27 receptor limits atherosclerosis in Ldlr−/− mice. Circ Res 111(10):1274–1285. doi:10.1161/CIRCRESAHA.112.277525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M, Kuchroo VK (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448(7152):484–487. doi:10.1038/nature05970

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kraft JD, Horzempa J, Davis C, Jung JY, Pena MM, Robinson CM (2013) Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses. Immunology 139(4):484–493. doi:10.1111/imm.12095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krumbiegel D, Anthogalidis-Voss C, Markus H, Zepp F, Meyer CU (2008) Enhanced expression of IL-27 mRNA in human newborns. Pediatr Allergy Immunol (official publication of the European Society of Pediatric Allergy and Immunology) 19(6):513–516. doi:10.1111/j.1399-3038.2007.00685.x

    Article  Google Scholar 

  • Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178(11):6730–6733

    Article  CAS  PubMed  Google Scholar 

  • Kwan BC, Tam LS, Lai KB, Lai FM, Li EK, Wang G, Chow KM, Li PK, Szeto CC (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48(12):1491–1497. doi:10.1093/rheumatology/kep255

    Article  CAS  Google Scholar 

  • Larousserie F, Pflanz S, Coulomb-L’Hermine A, Brousse N, Kastelein R, Devergne O (2004) Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 202(2):164–171. doi:10.1002/path.1508

    Article  CAS  PubMed  Google Scholar 

  • Lee BH, Carcamo WC, Chiorini JA, Peck AB, Nguyen CQ (2012) Gene therapy using IL-27 ameliorates Sjogren’s syndrome-like autoimmune exocrinopathy. Arthritis Res Ther 14(4):R172. doi:10.1186/ar3925

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee YS, Amadi-Obi A, Yu CR, Egwuagu CE (2011) Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10. Immunology 132(4):492–502. doi:10.1111/j.1365-2567.2010.03379.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leon AJ, Gomez E, Garrote JA, Bernardo D, Barrera A, Marcos JL, Fernandez-Salazar L, Velayos B, Blanco-Quiros A, Arranz E (2009) High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediat Inflamm 2009:580450. doi:10.1155/2009/580450

    Google Scholar 

  • Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, Hahm KB, Choi SC, Yun KJ, Chung HT, Chae SC (2009) Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol 24(10):1692–1696. doi:10.1111/j.1440-1746.2009.05901.x

    Article  CAS  PubMed  Google Scholar 

  • Li HY, Zhang DL, Ge J, Zhou H, Qi A, Ma L, Xue F, Zhou ZP, Yang RC (2012) Elevated interleukin-27 enhances the polarization of Th1/Tc1 cells and the production of proinflammatory cytokines in primary immune thrombocytopenia. Hum Immunol 73(3):240–247. doi:10.1016/j.humimm.2011.12.010

    Article  CAS  PubMed  Google Scholar 

  • Li JJ, Wang W, Baines KJ, Bowden NA, Hansbro PM, Gibson PG, Kumar RK, Foster PS, Yang M (2010a) IL-27/IFN-gamma induce MyD88-dependent steroid-resistant airway hyperresponsiveness by inhibiting glucocorticoid signaling in macrophages. J Immunol 185(7):4401–4409. doi:10.4049/jimmunol.1001039

    Article  CAS  PubMed  Google Scholar 

  • Li Q, Zhang L, Yang M, Xia R, Xia L, Liu F (2014) Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia. Scand J Immunol 80(4):276–282. doi:10.1111/sji.12197

    Article  CAS  PubMed  Google Scholar 

  • Li TT, Zhang T, Chen GM, Zhu QQ, Tao JH, Pan HF, Ye DQ (2010b) Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Invest Med (the official publication of the American Federation for Clinical Research) 58(5):737–739. doi:10.231/JIM.0b013e3181d88f7b

    Article  CAS  Google Scholar 

  • Liao KL, Bai XF, Friedman A (2014) Mathematical modeling of interleukin-27 induction of anti-tumor T cells response. PLoS ONE 9(3):e91844. doi:10.1371/journal.pone.0091844

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu G, Xu J, Wu H, Sun D, Zhang X, Zhu X, Magez S, Shi M (2015) IL-27 signaling is crucial for survival of mice infected with African trypanosomes via preventing lethal effects of CD4+ T cells and IFN-gamma. PLoS Pathog 11(7):e1005065. doi:10.1371/journal.ppat.1005065

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liu L, Cao Z, Chen J, Li R, Cao Y, Zhu C, Wu K, Wu J, Liu F, Zhu Y (2012a) Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem 287(15):11899–11910. doi:10.1074/jbc.M111.308064

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu L, Meng J, Zhang C, Duan Y, Zhao L, Wang S, Shan B (2012b) Effects on apoptosis and cell cycle arrest contribute to the antitumor responses of interleukin-27 mediated by retrovirus in human pancreatic carcinoma cells. Oncol Rep 27(5):1497–1503. doi:10.3892/or.2012.1663

    CAS  PubMed  Google Scholar 

  • Liu Z, Liu JQ, Talebian F, Wu LC, Li S, Bai XF (2013) IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol 43(2):468–479. doi:10.1002/eji.201242930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lv L, An X, Li H, Ma L (2016) Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells. Oncol Lett 11(2):1161–1166. doi:10.3892/ol.2015.3995

    PubMed  PubMed Central  Google Scholar 

  • Lyu S, Ye L, Wang O, Huang G, Yang F, Liu Y, Dong S (2015) IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population. OncoTargets Ther 8:1493–1497. doi:10.2147/OTT.S80255

    Article  CAS  Google Scholar 

  • Ma MC, Wang BW, Yeh TP, Wu JL, Chung TH, Tsui K, Chiang CF, Huang AJ, Huang YT (2015) Interleukin-27, a novel cytokine induced by ischemia-reperfusion injury in rat hearts, mediates cardioprotective effects via the gp130/STAT3 pathway. Basic Res Cardiol 110(3):22. doi:10.1007/s00395-015-0480-y

    Article  PubMed  CAS  Google Scholar 

  • Mas AE, Petitbarat M, Dubanchet S, Fay S, Ledee N, Chaouat G (2008) Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am J Reprod Immunol 59(4):323–338. doi:10.1111/j.1600-0897.2007.00567.x

    Article  CAS  PubMed  Google Scholar 

  • Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ (2013) IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 14(10):1054–1063. doi:10.1038/ni.2695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mathie SA, Dixon KL, Walker SA, Tyrrell V, Mondhe M, O’Donnell VB, Gregory LG, Lloyd CM (2015) Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge. Allergy 70(1):80–89. doi:10.1111/all.12536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matsui M, Kishida T, Nakano H, Yoshimoto K, Shin-Ya M, Shimada T, Nakai S, Imanishi J, Yoshimoto T, Hisa Y, Mazda O (2009) Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res 69(6):2523–2530. doi:10.1158/0008-5472.CAN-08-2793

    Article  CAS  PubMed  Google Scholar 

  • Matta BM, Raimondi G, Rosborough BR, Sumpter TL, Thomson AW (2012) IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J Immunol 188(11):5227–5237. doi:10.4049/jimmunol.1103382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meyer CU, Birkholz J, Weins N, Doganci A, Gehring S, Zepp F, Knuf M (2015) Dendritic cells change IL-27 production pattern during childhood. BMC Res Notes 8:232. doi:10.1186/s13104-015-1182-0

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mishima Y, Liu B, Hansen JJ, Sartor RB (2015) Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling. Cell Mol Gastroenterol Hepatol 1(3):295–310. doi:10.1016/j.jcmgh.2015.01.002

    Article  PubMed  PubMed Central  Google Scholar 

  • Mittal A, Murugaiyan G, Beynon V, Hu D, Weiner HL (2012) IL-27 induction of IL-21 from human CD8+ T cells induces granzyme B in an autocrine manner. Immunol Cell Biol 90(8):831–835. doi:10.1038/icb.2012.14

    Article  CAS  PubMed  Google Scholar 

  • Miyazaki Y, Inoue H, Matsumura M, Matsumoto K, Nakano T, Tsuda M, Hamano S, Yoshimura A, Yoshida H (2005) Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 175(4):2401–2407

    Article  CAS  PubMed  Google Scholar 

  • Moon SJ, Park JS, Heo YJ, Kang CM, Kim EK, Lim MA, Ryu JG, Park SJ, Park KS, Sung YC, Park SH, Kim HY, Min JK, Cho ML (2013) In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis. Exp Mol Med 45:e46. doi:10.1038/emm.2013.89

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Morishima N, Mizoguchi I, Okumura M, Chiba Y, Xu M, Shimizu M, Matsui M, Mizuguchi J, Yoshimoto T (2010) A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol 2010:605483. doi:10.1155/2010/605483

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T (2005) Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol 175(3):1686–1693

    Article  CAS  PubMed  Google Scholar 

  • Murugaiyan G, Beynon V, Pires Da Cunha A, Joller N, Weiner HL (2012) IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol 189(11):5277–5283. doi:10.4049/jimmunol.1200808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Natividad KD, Junankar SR, Mohd Redzwan N, Nair R, Wirasinha RC, King C, Brink R, Swarbrick A, Batten M (2013) Interleukin-27 signaling promotes immunity against endogenously arising murine tumors. PLoS ONE 8(3):e57469. doi:10.1371/journal.pone.0057469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nematollahi Z, Hadinedoushan H, Aflatoonian A, Eslami G, Ghasemi N (2015) The association between single nucleotide polymorphism in interleukin-27 gene and recurrent pregnancy loss in Iranian women. Iran J Reprod Med 13(4):209–214

    PubMed  PubMed Central  Google Scholar 

  • Niedbala W, Cai B, Wei X, Patakas A, Leung BP, McInnes IB, Liew FY (2008) Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 67(10):1474–1479. doi:10.1136/ard.2007.083360

    Article  CAS  PubMed  Google Scholar 

  • Oliveira WN, Ribeiro LE, Schrieffer A, Machado P, Carvalho EM, Bacellar O (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine 66(2):127–132. doi:10.1016/j.cyto.2013.12.016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paradowska-Gorycka A, Raszkiewicz B, Jurkowska M, Felis-Giemza A, Romanowska-Prochnicka K, Manczak M, Olesinska M (2014) Association of single nucleotide polymorphisms in the IL27 gene with rheumatoid arthritis. Scand J Immunol 80(4):298–305. doi:10.1111/sji.12209

    Article  CAS  PubMed  Google Scholar 

  • Park JS, Jung YO, Oh HJ, Park SJ, Heo YJ, Kang CM, Kwok SK, Ju JH, Park KS, Cho ML, Sung YC, Park SH, Kim HY (2012) Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma. Immunology 137(4):326–335. doi:10.1111/j.1365-2567.2012.03622.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pawaria S, Ramani K, Maers K, Liu Y, Kane LP, Levesque MC, Biswas PS (2014) Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus. J Immunol 193(7):3288–3295. doi:10.4049/jimmunol.1401322

    Article  CAS  PubMed  Google Scholar 

  • Pearl JE, Khader SA, Solache A, Gilmartin L, Ghilardi N, deSauvage F, Cooper AM (2004) IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 173(12):7490–7496

    Article  CAS  PubMed  Google Scholar 

  • Perona-Wright G, Kohlmeier JE, Bassity E, Freitas TC, Mohrs K, Cookenham T, Situ H, Pearce EJ, Woodland DL, Mohrs M (2012) Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response. Proc Natl Acad Sci USA 109(45):18535–18540. doi:10.1073/pnas.1119133109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pirhonen J, Siren J, Julkunen I, Matikainen S (2007) IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J Leukoc Biol 82(5):1185–1192. doi:10.1189/jlb.0307157

    Article  CAS  PubMed  Google Scholar 

  • Pulko V, Harris KJ, Liu X, Gibbons RM, Harrington SM, Krco CJ, Kwon ED, Dong H (2011) B7-h1 expressed by activated CD8 T cells is essential for their survival. J Immunol 187(11):5606–5614. doi:10.4049/jimmunol.1003976

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Quintana FJ, Yeste A, Mascanfroni ID (2015) Role and therapeutic value of dendritic cells in central nervous system autoimmunity. Cell Death Differ 22(2):215–224. doi:10.1038/cdd.2014.125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rajaiah R, Puttabyatappa M, Polumuri SK, Moudgil KD (2011) Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis. J Biol Chem 286(4):2817–2825. doi:10.1074/jbc.M110.187013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rinchai D, Khaenam P, Kewcharoenwong C, Buddhisa S, Pankla R, Chaussabel D, Bancroft GJ, Lertmemongkolchai G (2012) Production of interleukin-27 by human neutrophils regulates their function during bacterial infection. Eur J Immunol 42(12):3280–3290. doi:10.1002/eji.201242526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson CM, Nau GJ (2008) Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J Infect Dis 198(3):359–366. doi:10.1086/589774

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson KM, Lee B, Scheller EV, Mandalapu S, Enelow RI, Kolls JK, Alcorn JF (2015) The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia. Respir Res 16:10. doi:10.1186/s12931-015-0168-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Romme Christensen J, Bornsen L, Hesse D, Krakauer M, Sorensen PS, Sondergaard HB, Sellebjerg F (2012) Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. J Neuroinflammation 9:215. doi:10.1186/1742-2094-9-215

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T, Dai RM, Scheetz L, Lincoln E, Back TC, Powell D, Hurwitz AA, Sayers TJ, Kastelein R, Pavlakis GN, Felber BK, Trinchieri G, Wigginton JM (2009) Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol 182(7):4328–4338. doi:10.4049/jimmunol.0800471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Salcedo R, Stauffer JK, Lincoln E, Back TC, Hixon JA, Hahn C, Shafer-Weaver K, Malyguine A, Kastelein R, Wigginton JM (2004) IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J Immunol 173(12):7170–7182

    Article  CAS  PubMed  Google Scholar 

  • Sasaoka T, Ito M, Yamashita J, Nakajima K, Tanaka I, Narita M, Hara Y, Hada K, Takahashi M, Ohno Y, Matsuo T, Kaneshiro Y, Tanaka H, Kaneko K (2011) Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am J Physiol Gastrointest Liver Physiol 300(4):G568–G576. doi:10.1152/ajpgi.00329.2010

    Article  CAS  PubMed  Google Scholar 

  • Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn’s disease but not in ulcerative colitis. Inflamm Bowel Dis 11(1):16–23

    Article  PubMed  Google Scholar 

  • Sekar D, Hahn C, Brune B, Roberts E, Weigert A (2012) Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity. Eur J Immunol 42(6):1585–1598. doi:10.1002/eji.201142093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Senecal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, Moore CS, Prat A, Antel J, Arbour N (2016) Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses. Glia 64(4):553–569. doi:10.1002/glia.22948

    Article  PubMed  Google Scholar 

  • Shao J, Tian L, Lei B, Wei L, Yang Y, Kijlstra A, Yang P (2012) AAV2-mediated subretinal gene transfer of mIL-27p28 attenuates experimental autoimmune uveoretinitis in mice. PLoS ONE 7(5):e37773. doi:10.1371/journal.pone.0037773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sharma G, Dutta RK, Khan MA, Ishaq M, Sharma K, Malhotra H, Majumdar S (2014) IL-27 inhibits IFN-gamma induced autophagy by concomitant induction of JAK/PI3 K/Akt/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages. Int J Biochem Cell Biol 55:335–347. doi:10.1016/j.biocel.2014.08.022

    Article  CAS  PubMed  Google Scholar 

  • Shen H, Xia L, Lu J (2012) Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases. Cytokine 60(2):334–337. doi:10.1016/j.cyto.2012.07.011

    Article  CAS  PubMed  Google Scholar 

  • Shen H, Xia L, Xiao W, Lu J (2011) Increased levels of interleukin-27 in patients with rheumatoid arthritis. Arthritis Rheum 63(3):860–861. doi:10.1002/art.30180

    Article  CAS  PubMed  Google Scholar 

  • Shen H, Xia LP, Lu J (2013) Elevated levels of interleukin-27 and effect on production of interferon-gamma and interleukin-17 in patients with Behcet’s disease. Scand J Rheumatol 42(1):48–51. doi:10.3109/03009742.2012.704391

    Article  CAS  PubMed  Google Scholar 

  • Shibata S, Tada Y, Kanda N, Nashiro K, Kamata M, Karakawa M, Miyagaki T, Kai H, Saeki H, Shirakata Y, Watanabe S, Tamaki K, Sato S (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130(4):1034–1039. doi:10.1038/jid.2009.349

    Article  CAS  PubMed  Google Scholar 

  • Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M, Iwakura Y, Takeda Y, Luster AD, Mizuguchi J, Yoshimoto T (2006) Antiangiogenic and antitumor activities of IL-27. J Immunol 176(12):7317–7324

    Article  CAS  PubMed  Google Scholar 

  • Shinozaki Y, Wang S, Miyazaki Y, Miyazaki K, Yamada H, Yoshikai Y, Hara H, Yoshida H (2009) Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int J Cancer 124(6):1372–1378. doi:10.1002/ijc.24107

    Article  CAS  PubMed  Google Scholar 

  • Skouras VS, Magkouta SF, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I (2015) Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence. Infect Dis (Lond) 47(7):477–483. doi:10.3109/23744235.2015.1019919

    Article  CAS  Google Scholar 

  • Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, Masutani K, Igawa T, Akahoshi M, Miyake K, Takeda A, Yoshimura A, Hamano S, Yoshida H (2008) Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis 67(10):1461–1467. doi:10.1136/ard.2007.077537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun M, Yan D, Jiang S, Gu X, Ma W (2014) Diagnostic value of interleukin-27 in tuberculous pleural effusion. Zhonghua yi xue za zhi 94(34):2641–2644

    CAS  PubMed  Google Scholar 

  • Swaminathan S, Hu Z, Rupert AW, Higgins JM, Dewar RL, Stevens R, Chen Q, Rehm CA, Metcalf JA, Baseler MW, Lane HC, Imamichi T (2014) Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection. PloS one 9(6):e98989. doi:10.1371/journal.pone.0098989

    Google Scholar 

  • Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH, Fletcher JM (2011) IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav Immun 25(6):1170–1181. doi:10.1016/j.bbi.2011.03.007

    Article  CAS  PubMed  Google Scholar 

  • Tanaka T, Obana M, Mohri T, Ebara M, Otani Y, Maeda M, Fujio Y (2015) Interleukin-27 induces the endothelial differentiation in Sca-1+ cardiac resident stem cells. Cytokine 75(2):365–372. doi:10.1016/j.cyto.2015.06.009

    Article  CAS  PubMed  Google Scholar 

  • Tang SC, Fan XH, Pan QM, Sun QS, Liu Y (2015) Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis. J Neurol Sci 348(1–2):174–180. doi:10.1016/j.jns.2014.11.035

    Article  CAS  PubMed  Google Scholar 

  • Tang YJ, Wang JL, Nong LG, Lan CG, Zha ZG, Liao PH (2014) Associations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk. Medicine 93(10):e56. doi:10.1097/MD.0000000000000056

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tanida S, Yoshitomi H, Ishikawa M, Kasahara T, Murata K, Shibuya H, Ito H, Nakamura T (2011) IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. Cytokine 55(2):237–244. doi:10.1016/j.cyto.2011.04.020

    Article  CAS  PubMed  Google Scholar 

  • Tassi E, Braga M, Longhi R, Gavazzi F, Parmiani G, Di Carlo V, Protti MP (2009) Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients. PLoS ONE 4(10):e7234. doi:10.1371/journal.pone.0007234

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tojo G, Fujimura T, Kambayashi Y, Aiba S (2012) Systemic lupus erythematosus accompanied by psoriasis induces IL-27-producing cells in both affected areas of the skin. Case Rep Dermatol 4(2):181–185. doi:10.1159/000342803

    Article  PubMed  PubMed Central  Google Scholar 

  • Tolouei S, Ghaedi K, Khamesipour A, Akbari M, Baghaei M, Hasheminia S, Narimani M, Hejazi S (2012) IL-23 and IL-27 levels in macrophages collected from peripheral blood of patients with healing vs non-healing form of cutaneous leishmaniasis. Iran J Parasitol 7(1):18–25

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tormo AJ, Beaupre LA, Elson G, Crabe S, Gauchat JF (2013) A polyglutamic acid motif confers IL-27 hydroxyapatite and bone-binding properties. J Immunol 190(6):2931–2937. doi:10.4049/jimmunol.1201460

    Article  CAS  PubMed  Google Scholar 

  • Tsoumakidou M, Tousa S, Semitekolou M, Panagiotou P, Panagiotou A, Morianos I, Litsiou E, Trochoutsou AI, Konstantinou M, Potaris K, Footitt J, Mallia P, Zakynthinos S, Johnston SL, Xanthou G (2014) Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand. J Allergy Clin Immunol 134(4):944–954 e948. doi:10.1016/j.jaci.2014.05.045

    Google Scholar 

  • Valdes L, San Jose E, Ferreiro L, Golpe A, Gude F, Alvarez-Dobano JM, Pereyra MF, Toubes ME, Gonzalez-Barcala FJ (2014) Interleukin 27 could be useful in the diagnosis of tuberculous pleural effusions. Respir Care 59(3):399–405. doi:10.4187/respcare.02749

    Article  PubMed  Google Scholar 

  • Visperas A, Do JS, Bulek K, Li X, Min B (2014) IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice. Mucosal Immunol 7(3):625–633. doi:10.1038/mi.2013.82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P (2012a) Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 53(8):4668–4675. doi:10.1167/iovs.12-9863

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P (2014a) Decreased interleukin 27 expression is associated with active uveitis in Behcet’s disease. Arthritis Res Ther 16(3):R117. doi:10.1186/ar4570

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang D, Eiz-Vesper B, Zeitvogel J, Dressel R, Werfel T, Wittmann M (2011) Human keratinocytes release high levels of inducible heat shock protein 70 that enhances peptide uptake. Exp Dermatol 20(8):637–641. doi:10.1111/j.1600-0625.2011.01287.x

    Article  CAS  PubMed  Google Scholar 

  • Wang HL, Zhang HY, Zhai ZL, Zhou X (2012b) The correlation between hepatitis B virus infection and IL-27. Bio-Med Mater Eng 22(1–3):187–193. doi:10.3233/BME-2012-0706

    Google Scholar 

  • Wang S, Miyazaki Y, Shinozaki Y, Yoshida H (2007) Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol 179(10):6421–6428

    Article  CAS  PubMed  Google Scholar 

  • Wang WJ, Liu FJ, Qu HM, Hao CF, Qu QL, Xiong W, Bao HC, Wang XR (2013) Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage. J Reprod Immunol 99(1–2):39–45. doi:10.1016/j.jri.2013.04.002

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Wang L, Fan R, Zhou J, Zhong J (2014b) Association of IL-27 gene three polymorphisms with Crohn’s disease susceptibility in a Chinese Han population. Int J Clin Exp Pathol 7(12):8952–8957

    PubMed  PubMed Central  Google Scholar 

  • Wei J, Xia S, Sun H, Zhang S, Wang J, Zhao H, Wu X, Chen X, Hao J, Zhou X, Zhu Z, Gao X, Gao JX, Wang P, Wu Z, Zhao L, Yin Z (2013) Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells. J Immunol 191(1):500–508. doi:10.4049/jimmunol.1300328

    Article  CAS  PubMed  Google Scholar 

  • Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, Neurath MF (2006) Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203(8):1875–1881. doi:10.1084/jem.20060471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wittmann M, Doble R, Bachmann M, Pfeilschifter J, Werfel T, Muhl H (2012) IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS ONE 7(6):e38751. doi:10.1371/journal.pone.0038751

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wittmann M, Zeitvogel J, Wang D, Werfel T (2009) IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 124(1):81–89. doi:10.1016/j.jaci.2009.04.026

    Article  CAS  PubMed  Google Scholar 

  • Wojno ED, Hosken N, Stumhofer JS, O’Hara AC, Mauldin E, Fang Q, Turka LA, Levin SD, Hunter CA (2011) A role for IL-27 in limiting T regulatory cell populations. J Immunol 187(1):266–273. doi:10.4049/jimmunol.1004182

    Article  CAS  PubMed  Google Scholar 

  • Wong CK, da Chen P, Tam LS, Li EK, Yin YB, Lam CW (2010) Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 12(4):R129. doi:10.1186/ar3067

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wong HR, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Bigham MT, Sen A, Nowak J, Quasney M, Henricksen JW, Chopra A, Banschbach S, Beckman E, Harmon K, Lahni P, Shanley TP (2012) Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care 16(5):R213. doi:10.1186/cc11847

    Article  PubMed  PubMed Central  Google Scholar 

  • Wong HR, Liu KD, Kangelaris KN, Lahni P, Calfee CS (2014) Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults. J Crit Care 29(5):718–722. doi:10.1016/j.jcrc.2014.04.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu YB, Ye ZJ, Qin SM, Wu C, Chen YQ, Shi HZ (2013) Combined detections of interleukin 27, interferon-gamma, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy. Chin Med J 126(17):3215–3221

    CAS  PubMed  Google Scholar 

  • Xia H, Ye ZJ, Zhou Q, You WJ, Cui A, Wang XJ, Zhai K, Jin XG, Tong ZH, Shi HZ (2014a) IL-27 and IL-27-producing CD4+ T cells in human tuberculous pleural effusion. Tuberculosis (Edinb) 94(6):579–588. doi:10.1016/j.tube.2014.07.003

    Article  CAS  Google Scholar 

  • Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, Sun Y, Zhao H, Zhang S, Wen T, Zhou X, Gao JX, Wang P, Wu Z, Zhao L, Yin Z (2014b) A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. doi:10.1189/jlb.0713371

    PubMed Central  Google Scholar 

  • Yamamoto-Furusho JK, Posadas-Sanchez R, Alvarez-Leon E, Vargas-Alarcon G (2016) Protective role of Interleukin 27 (IL-27) gene polymorphisms in patients with ulcerative colitis. Immunol Lett 172:79–83. doi:10.1016/j.imlet.2016.02.010

    Article  CAS  PubMed  Google Scholar 

  • Yan J, Shang X, Rong X (2015) Relationship between IL-27 gene polymorphism and susceptibility of rheumatoid arthritis in Chinese Han population. Int J Clin Exp Med 8(4):6262–6266

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yang JF, Tao HQ, Liu YM, Zhan XX, Liu Y, Wang XY, Wang JH, Mu LL, Yang LL, Gao ZM, Kong QF, Wang GY, Han JH, Sun B, Li HL (2012a) Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice. Clin Exp Immunol 170(3):254–265. doi:10.1111/j.1365-2249.2012.04661.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang WB, Liang QL, Ye ZJ, Niu CM, Ma WL, Xiong XZ, Du RH, Zhou Q, Zhang JC, Shi HZ (2012b) Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions. PLoS ONE 7(7):e40450. doi:10.1371/journal.pone.0040450

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yao G, Shi B, Qi J, Wang Y, Chen W, Tang X, Wang D, Feng X, Sun L (2015) Deficiency of IL-27 Exacerbate Sjögren’s Syndrome through inhibiting differentiation of type 1 regulatory T cells [abstract]. Arthritis Rheumatol 67(suppl 10). http://acrabstracts.org/abstract/deficiency-of-il-27-exacerbate-sjogrens-syndrome-through-inhibiting-differentiation-of-type-1-regulatory-t-cells/. Accessed 16 Feb 2016

  • Yao L, Wang M, Niu Z, Liu Q, Gao X, Zhou L, Liao Q, Zhao Y (2016) Interleukin-27 inhibits malignant behaviors of pancreatic cancer cells by targeting M2 polarized tumor associated macrophages. Cytokine. doi:10.1016/j.cyto.2015.12.003

    PubMed  Google Scholar 

  • Ye ZJ, Xu LL, Zhou Q, Cui A, Wang XJ, Zhai K, Wang Z, Tong ZH, Shi HZ (2015) Recruitment of IL-27-producing CD4(+) T cells and effect of IL-27 on pleural mesothelial cells in tuberculous pleurisy. Lung 193(4):539–548. doi:10.1007/s00408-015-9738-2

    Article  CAS  PubMed  Google Scholar 

  • Yin N, Zhang H, Luo X, Ding Y, Xiao X, Liu X, Shan N, Zhang X, Deng Q, Zhuang B, Qi H (2014) IL-27 activates human trophoblasts to express IP-10 and IL-6: implications in the immunopathophysiology of preeclampsia. Mediat Inflamm 2014:926875. doi:10.1155/2014/926875

    Google Scholar 

  • Yoshimoto T, Morishima N, Mizoguchi I, Shimizu M, Nagai H, Oniki S, Oka M, Nishigori C, Mizuguchi J (2008) Antiproliferative activity of IL-27 on melanoma. J Immunol 180(10):6527–6535

    Article  CAS  PubMed  Google Scholar 

  • Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K (2007) IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 179(7):4415–4423

    Article  CAS  PubMed  Google Scholar 

  • Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Muroi E, Ogawa F, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S (2011) Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Ann Rheum Dis 70(1):194–200. doi:10.1136/ard.2009.121053

    Article  CAS  PubMed  Google Scholar 

  • Zhang GL, Xie DY, Ye YN, Lin CS, Zhang XH, Zheng YB, Huang ZL, Peng L, Gao ZL (2014a) High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. Liver Int (official journal of the International Association for the Study of the Liver) 34(2):266–273. doi:10.1111/liv.12268

    Google Scholar 

  • Zhang J, Tian H, Li C, Cheng L, Zhang S, Zhang X, Wang R, Xu F, Dai L, Shi G, Chen X, Li Y, Du T, Deng J, Liu Y, Yang Y, Wei Y, Deng H (2013) Antitumor effects obtained by autologous Lewis lung cancer cell vaccine engineered to secrete mouse interleukin 27 by means of cationic liposome. Mol Immunol 55(3–4):264–274. doi:10.1016/j.molimm.2013.02.006

    Article  CAS  PubMed  Google Scholar 

  • Zhang YF, Zhao AD (2016) Common polymorphisms in IL-27 genes may contribute to risk of various human diseases in asian populations: a meta-analysis. Med Sci Monit Int Med J Exp Clin Res 22:766–775

    Article  Google Scholar 

  • Zhang Z, Zhou B, Wu Y, Gao Q, Zhang K, Song Y, Zhang L, Xi M (2014b) Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics 66(2):85–92. doi:10.1007/s00251-013-0753-2

    Article  CAS  PubMed  Google Scholar 

  • Zhou B, Zhang P, Tang T, Liao H, Zhang K, Pu Y, Chen P, Song Y, Zhang L (2015) Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer. BMC Cancer 15:433. doi:10.1186/s12885-015-1459-7

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhu C, Sakuishi K, Xiao S, Sun Z, Zaghouani S, Gu G, Wang C, Tan DJ, Wu C, Rangachari M, Pertel T, Jin HT, Ahmed R, Anderson AC, Kuchroo VK (2015) An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction. Nat Commun 6:6072. doi:10.1038/ncomms7072

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu S, Lee DA, Li S (2010) IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 184(5):2348–2354. doi:10.4049/jimmunol.0902371

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zolochevska O, Diaz-Quinones AO, Ellis J, Figueiredo ML (2013a) Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro. J Cell Physiol 228(5):1127–1136. doi:10.1002/jcp.24265

    Article  CAS  PubMed  Google Scholar 

  • Zolochevska O, Ellis J, Parelkar S, Chan-Seng D, Emrick T, Wei J, Patrikeev I, Motamedi M, Figueiredo ML (2013b) Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone. Hum Gene Ther 24(12):970–981. doi:10.1089/hum.2013.091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zorzoli A, Di Carlo E, Cocco C, Ognio E, Ribatti D, Ferretti E, Dufour C, Locatelli F, Montagna D, Airoldi I (2012) Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice. Clin Cancer Res (an official journal of the American Association for Cancer Research) 18(6):1630–1640. doi:10.1158/1078-0432.CCR-11-2432

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marek Jankowski .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 The Author(s)

About this chapter

Cite this chapter

Jankowski, M., Wandtke, T. (2016). IL-27 in Health and Disease. In: Interleukin-27: Biological Properties and Clinical Application. SpringerBriefs in Immunology. Springer, Cham. https://doi.org/10.1007/978-3-319-39664-4_3

Download citation

Publish with us

Policies and ethics